Indianz.Com > COVID-19 > Indian Health Service (Department of Health and Human Services)
https://indianz.com/covid19/?p=15479
Posted: October 15, 2021
ihscovid19vaccine

Image: Indian Health Service

The Indian Health Service has updated its coronavirus data, showing COVID-19 vaccination distribution and administration as of October 11, 2021.

According to the data, the IHS has distributed 2,126,975 COVID-19 vaccine doses across 11 areas of Indian Country. Of that amount, 1,674,466 have been administered, representing 78.7 percent of the total.

The number of vaccines distributed by the IHS increased by almost 1.5 percent, according to a comparison of data from October 4.Meanwhile, the number of vaccines administered grew by about 1.5 percent.

The Oklahoma City Area, where COVID-19 cases have increased considerably since the availability of the vaccine, continues to account for the most vaccines received (541,460) and administered (427,569). The Navajo Area, where the pandemic has exacted a disproportionate toll since the spring of 2020, comes in second (305,025 distributed, 272,352 administered) while the California Area comes in third (254,605 distributed, 172,305 administered).

In all three areas, the number of doses administered, as well as the number of doses distributed, increased from the week prior. The three regions account for the largest number of IHS users, with the Phoenix Area also accounting for a large number (219,440 distributed, 178,910 administered). The Phoenix Area has been disproportionately affected by COVID-19 as well.

According to the IHS, vaccination distribution and administration will be updated weekly across the 11 areas that are receiving doses directly from the agency.

Tribal health facilities in Alaska have chosen to receive their COVID-19 vaccine supplies from the state, so their region is not included in the data.

COVID-19 Vaccine Distribution and Administration by IHS Area

As of October 11, 2021, the IHS is distributing all three COVID-19 vaccines currently authorized or approved in the U.S, including Pfizer-BioNTech, Moderna, and Janssen/Johnson & Johnson. The table below shows the total number of vaccine doses distributed and administered to date, per IHS Area, for facilities that chose to receive vaccine through the IHS jurisdiction. The data includes COVID-19 vaccinations administered to all ages and specialty groups authorized for emergency use or fully licensed by the Food and Drug Administration (FDA). The IHS administration rate is 79 percent. The Albuquerque Area has a greater than 100 percent administration rate, which may be due to vaccine overfill in the vials for both Pfizer and Moderna products.The IHS jurisdiction is administering all available full doses in accordance with FDA guidance.

Area Total Doses Distributed* Total Doses Administered**
Albuquerque 141,265 142,041
Bemidji 180,545 134,714
Billings 85,365 56,971
California 254,605 172,305
Great Plains 158,230 112,019
Nashville 113,185 82,112
Navajo 305,025 272,352
Oklahoma City 541,460 427,569
Phoenix 219,440 178,910
Portland 114,065 84,469
Tucson 13,790 11,004
Grand Total 2,126,975 1,674,466

*Distributed Data Source: IHS National Supply Service Center, includes total doses ordered and delivered by October 8, 2021, to facilities that chose the IHS jurisdiction for vaccine distribution.

**Administered Data Source: Data is reported from the Vaccine Administration Management System (VAMS) and IHS Central Aggregator Service (CAS). Data may be different than data on the CDC COVID-19 Vaccine Tracker due to lags and ongoing quality review of data, including resolving data errors.

Note:The COVID-19 Vaccine Distribution and Administration by IHS Area data is only reflective of facilities that chose the IHS jurisdiction for vaccine distribution. Alaska Area data is not reported as all tribes chose to receive COVID-19 vaccine from the State of Alaska. The Tucson Area data only includes one tribe that chose the IHS jurisdiction for vaccine distribution.

Source: Indian Health Service (https://www.ihs.gov/coronavirus)

Join the Conversation